Thymine–DNA glycosylase (TDG) has recently been validated as a possible drug target in melanoma: its knockdown causes cell cycle arrest, senescence, and cell death in melanoma cell lines but not in normal cells and prevents tumor growth in a xenograft model [91]. The gene discussed is TDG; the disease is melanoma.